BioOne Corporation
Home >>Mission
The Next Step for Safer Blood
Blood transfusions are playing an important role to support the cutting-edge therapies. And the blood supply becomes safer than ever before. However, some risks still exist despite many improvements in viral detections.

We are pleased to introduce INTERCEPT Blood System, an innovative and unique system to inactivate pathogens and lymphocytes in blood products, developed by Cerus Corporation.

BioOne will offer you the integrated solution to take next step for safer blood supply in East Asia Countries.

BioOne Corporation
President & CEO Akihiro Shimosaka, Ph. D.

Copyright (C) 2008 All rights reserved BioOne Corporation
BioOne Corporation News&Event Mission Company Profile Products Profile Contact Us Privacy Policy Home Japanese